A multidimensional approach to impulsivity in Parkinson's disease: measurement and structural invariance of the UPPS Impulsive Behaviour Scale

Bayard, Sophie; Joly, Emilie; Ghisletta, Paolo; Rossignol, A.; Herades, Y.; Gény, Christian; Gély‐Nargeot, Marie‐Christine; Rochat, Lucien

doi:10.1017/s0033291716001586

Cited by 15 publications

(21 citation statements)

References 49 publications

(63 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results emphasize that impulsive behavioral changes occur in PD, regardless of ICB status. Indeed, the LASSO analysis reveals most questions distinguishing PD from HCs that align with the changes to attention or inhibitory control, as demonstrated by high ratings on questions such as: “I don’t ‘pay attention’,” “I (don’t) plan tasks carefully,” “I am (not) self‐controlled,” and “I buy things on impulse.” Although the Urgency‐Premeditation‐Perseverance‐Sensation seeking Impulsive Behavior Scale (UPPS) measures different dimensions of impulsivity than the BIS‐11, our findings align well with the overall findings from a study that found that subjects with PD had lower premeditation and greater risk taking than HCs 66 . While it is difficult to compare BIS‐11 findings, we believe that the changes in self‐control and cognitive complexity agree with this finding.…”

Section: Discussionsupporting

confidence: 83%

“…Although patients with dementia were excluded, in the absence of formal neuropsychological testing, it is possible that some patients may have met criteria for mild cognitive impairment. A previous study found that there was no difference in BIS‐11 scores and domain scores between PD and PD‐MCI patients 66 . We hypothesize that self‐reported problems with attention in this population with PD may reflect early dysexecutive symptoms, of which the MoCA screening is heavily weighted.…”

Section: Discussionmentioning

confidence: 68%

See 1 more Smart Citation

Self‐reported rates of impulsivity in Parkinson’s Disease

Aumann

Stark

Hughes

et al. 2020

Ann Clin Transl Neurol

View full text Add to dashboard Cite

Objective: Impulsive decision-making is characterized by actions taken without considering consequences. Patients with Parkinson's disease (PD) who receive dopaminergic treatment, especially dopamine agonists, are at risk of developing impulsive-compulsive behaviors (ICBs). We assessed impulse-related changes across a large heterogeneous PD population using the Barratt impulsivity scale (BIS-11) by evaluating BIS-11 first-and second-order factors. Methods: We assessed a total of 204 subjects: 93 healthy controls (HCs), and 68 ICB-and 43 ICB + PD patients who completed the BIS-11. Using a general linear model and a least absolute shrinkage and selection operation regression, we compared BIS-11 scores between the HC, ICB-PD, and ICB + PD groups. Results: Patients with PD rated themselves as more impulsive than HCs in the BIS-11 total score, second-order attention domain, and first-order attention and selfcontrol domains. ICB + patients recorded higher total scores as well as higher scores in the second-order non-planning domain and in self-control and cognitive complexity than ICB-patients. Interpretation: These results indicate that the patients with PD show particular problems with attentional control, whereas ICB + patients show a distinct problem in cognitive control and complexity. Additionally, it appears that all patients with PD are more impulsive than their age-and sex-matched healthy peers. Increased impulsivity may be a result of the disease course, or attributed to dopaminergic medication use, but these results emphasize the importance of the cognitive components of impulsivity in patients with PD.

show abstract

Section: Discussionsupporting

confidence: 83%

Section: Discussionmentioning

confidence: 68%

Self‐reported rates of impulsivity in Parkinson’s Disease

Aumann

Stark

Hughes

et al. 2020

Ann Clin Transl Neurol

View full text Add to dashboard Cite

show abstract

“…Lower perseverance was reported in people with obsessive-compulsive symptoms, compulsive buying (74-77), bulimia (78), and self-injury behavior (79). One study found lower perseverance in PD patients with and without ICD (7). PD-ICD patients in our sample did not manifest higher levels of Urgency, which represents the aspect of emotional impulsivity.…”

Section: Discussioncontrasting

confidence: 38%

“…Research using self-reported methods concluded that people with certain personality traits are in higher risk of developing ICD. Specifically, associations between ICD and higher novelty/sensation seeking, compulsivity, depression, and anxiety were found (3,(7)(8)(9). Impulsive personal traits have been previously associated with ICD in PD.…”

Section: Introductionmentioning

confidence: 79%

Behavioral and Neuroanatomical Account of Impulsivity in Parkinson's Disease

et al. 2020

View full text Add to dashboard Cite

show abstract

“…However studies in PD in the absence of clinically defined impulse control disorder are lacking and even the ones with late stage ICD [49,50] lack simultaneous assessment of all impulsivity domains. Personality traits based scales [51] such as the Urgency-Premeditation-Perseverance-Sensation seeking Impulsive Behaviour Scale, are clinically useful, but do not address the neurobehavioural dimensions investigated in our study.…”

Section: Discussionmentioning

confidence: 99%

Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment

et al. 2019

View full text Add to dashboard Cite

Impulse control disorders (ICD) may occur in Parkinson’s disease (PD) although it remains to be understood if such deficits may occur even in the absence of a formal ICD diagnosis. Moreover, studies addressing simultaneously distinct neurobehavioral domains, such as cognitive, proactive and reactive motor impulsivity, are still lacking. Here, we aimed to investigate if reactive, proactive and cognitive impulsivity involving risk taking are concomitantly affected in medicated PD patients, and whether deficits were dependent on response strategies, such as speed accuracy tradeoffs, or the proportion of omission vs. commission errors. We assessed three different impulsivity domains in a sample of 21 PD patients and 13 matched controls. We found impaired impulsivity in both reactive (p = 0.042) and cognitive domains (p = 0.015) for the PD patients, irrespective of response strategy. For the latter, effect sizes were larger for the actions related with reward processing (p = 0.017, d Cohen = 0.9). In the proactive impulsivity task, PD patients showed significantly increased number of omissions (p = 0.041), a response strategy which was associated with preserved number of commission errors. Moreover, the number of premature and proactive response errors were correlated with disease stage. Our findings suggest that PD ON medication is characterized compared to healthy controls by impairment across several impulsivity domains, which is moderated in the proactive domain by the response strategy.

show abstract

A multidimensional approach to impulsivity in Parkinson's disease: measurement and structural invariance of the UPPS Impulsive Behaviour Scale

Cited by 15 publications

References 49 publications

Self‐reported rates of impulsivity in Parkinson’s Disease

Self‐reported rates of impulsivity in Parkinson’s Disease

Behavioral and Neuroanatomical Account of Impulsivity in Parkinson's Disease

Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment

Contact Info

Product

Resources

About